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Dear Editor,
Tuberculosis (TB) is a worldwide disease. 
It is estimated that one third of the world’s 
population is infected with Mycobacterium 
tuberculosis (Mtb).1 Latent TB (Mtb infec-
tion) is detected by tuberculin skin test (TST). 
This test evaluates the cell-mediated immune 
response to purified protein derivative (PPD) 
obtained from culture of the Mtb complex 
bacteria. TB latently infected individual is 
characterized by Mtb infection without devel-
opment of symptoms. TST is useful in screen-
ing for highly exposed individuals, such as 
contacts of TB patients and health care work-
ers. However, the accuracy of this test depends 
on results interpretation. There are two possi-
ble interpretations for a positive TST: an old 
response that could be recalled in a booster 
phenomenon or a recent Mtb infection, which 
is called conversion. The interpretation of the 
TST result affects directly the physician’s ac-
tions in order to avoid active TB development; 
it is well-known that a recent TB infected 
individual has 10%-20% more chances of de-
veloping active TB than individuals who had 
an old TB infection. It is also believed that in-
dividuals recently infected (those under TST 
positive conversion after exposure to an active 
TB patient) are at high risk of becoming ill, 
probably within two years after Mtb infection. 
Prophylactic therapy with isoniazid 
was shown to be effective to avoid TB 
development among latently infected indi-
viduals.2 However, because one third of the 
world’s population is infected with TB, this 
prophylaxis seems unlikely to be achieved. 
Therefore, the development of a quick test 
able to distinguish between TB latent indi-
viduals and those at high risk of developing 
active disease is urgent. We previously dem-
onstrated that health care workers from a TB 
reference hospital who were recently infected 
(TST conversion) showed augmented and 
distinct antibody levels (IgM) against HspX 
Mtb.3 Along with this argument, we propose 
in this study to evaluate the application of 
an enzyme linked immunosorbent assay 
(ELISA) against HspX in the screening of TB 
recently infected individuals (TST convert-
ed) at high risk of developing active disease 
among contacts of pulmonary TB patients.
One hundred seventy-seven contacts from 
45 pulmonary TB patients were submitted to 
TST. Upon patient’s diagnosis, blood was har-
vested, after 4 weeks, 12 weeks, 6 months and 
1 year, in order to evaluate the Mtb’s infection 
(TST positive/conversion) and the dosages 
of IgM/IgG anti-HspX (ELISA), respectively. 
During the follow-up period, two contacts TST 
positive developed active TB, 8 converted their 
TST into positive and 6 boosted their TST. Ta-
ble 1 shows the results of all contacts grouped 
by their socio-epidemiologic characteristics. 
ELISA for IgM-HspX did not reach satisfac-
tory performance (ROC area = 0.55) and 
consequently all groups showed similar 
antibody levels. The role of antibodies in TB 
is discredited because Mtb’s replication is 
intracellular4 and their use is restricted to diag-
nosis of active disease. However, it was recently 
shown that expression of Fcγ receptor can 
distinguish TB patients latently infected from 
non-infected individuals.5 We may speculate if 
the lowest anti-Hspx antibodies levels were due 
to a consumption of these molecules, which 
may play a role in Mtb infection in TST con-
verted contacts. The other groups of contacts 
(TST negative, boosted), which presented 
higher levels of anti-HspX also did not develop 
active TB.
We concluded that IgM/IgG-HspX levels 
in latently infected individuals did not consti-
tute a risk factor for the development of active 
tuberculosis. Therefore, it cannot be used to 
identify latent individuals who will develop ac-
tive tuberculosis. Este é um artigo Open Access sob
 a licença de CC BY-NC-ND
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Table 1. Anti-HspX antibody levels of contacts of PTB pa-
tients according to socio-epidemiological characteristics
  IgM-Hspx (O.D.)
Gender 
 Female 0.853 ± 0.39 (p = 0.53)
 Male 0.805 ± 0.36 
Age 
 < 16 years 0.895 ± 0.36 (p = 0.30)
 16 years 0.816 ± 0.37 
BCG 
 Yes 0.805 ± 0.35 (p = 0.25)
 No 0.908 ± 0.43
Relatives 
 Yes 0.849 ± 0.39 (p = 0.28)
 No 0.761 ± 0.31
Same household 
 Yes 0.828 ± 0.38 (p = 0.89)
 No 0.823 ± 0.33
Contact frequency 
 Daily 0.830 ± 0.38 (p = 0.96)
 Weekly 0.798 ± 0.27 
Kind of contact 
 Family 0.849 ± 0.38 (p = 0.17)
 Institutional 0.732 ± 0.30
Comorbidity 
 Present 0.863 ± 0.40 (p = 0.48)
 Absent  0.820 ± 0.36
Latent TB and immune response to HSP-x
